LDLR promotes autophagy‐mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway

Abstract Autophagy is one of the underlying causes of resistance to many antitumor drugs, including cisplatin (DDP). The low‐density lipoprotein receptor (LDLR) is a regulator of ovarian cancer (OC) progression. However, whether LDLR regulates DDP resistance in OC via autophagy‐related pathways rema...

Full description

Bibliographic Details
Main Authors: Lei Liu, Yu‐Hui Sun, Ran An, Rong‐Jie Cheng, Nan Li, Jian‐Hua Zheng
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Kaohsiung Journal of Medical Sciences
Subjects:
Online Access:https://doi.org/10.1002/kjm2.12696
_version_ 1797744358515015680
author Lei Liu
Yu‐Hui Sun
Ran An
Rong‐Jie Cheng
Nan Li
Jian‐Hua Zheng
author_facet Lei Liu
Yu‐Hui Sun
Ran An
Rong‐Jie Cheng
Nan Li
Jian‐Hua Zheng
author_sort Lei Liu
collection DOAJ
description Abstract Autophagy is one of the underlying causes of resistance to many antitumor drugs, including cisplatin (DDP). The low‐density lipoprotein receptor (LDLR) is a regulator of ovarian cancer (OC) progression. However, whether LDLR regulates DDP resistance in OC via autophagy‐related pathways remains unclear. LDLR expression was measured by quantitative real‐time PCR, western blot (WB) and IHC staining. A Cell Counting Kit 8 assay was employed to evaluate DDP resistance and cell viability, and flow cytometry was used to assess apoptosis. WB analysis was employed to evaluate the expression of autophagy‐related proteins and PI3K/AKT/mTOR signaling pathway proteins. The autophagolysosomes and the fluorescence intensity of LC3 were observed by transmission electron microscopy and immunofluorescence staining, respectively. A xenograft tumor model was established to explore the role of LDLR in vivo. LDLR was highly expressed in OC cells, which was correlated with disease progression. In DDP‐resistant OC cells, high LDLR expression was related to DDP resistance and autophagy. Downregulation of LDLR repressed autophagy and growth in DDP‐resistant OC cell lines by activating the PI3K/AKT/mTOR pathway, and these effects were eliminated by an mTOR inhibitor. In addition, LDLR knockdown also reduced OC tumor growth by suppressing autophagy associated with the PI3K/AKT/mTOR pathway. LDLR promoted autophagy‐mediated DDP resistance in OC associated with the PI3K/AKT/mTOR pathway, indicating that LDLR might be a new target to prevent DDP resistance in OC patients.
first_indexed 2024-03-12T15:08:37Z
format Article
id doaj.art-cf77ee522a274176b828dc3593f6241d
institution Directory Open Access Journal
issn 1607-551X
2410-8650
language English
last_indexed 2024-03-12T15:08:37Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series Kaohsiung Journal of Medical Sciences
spelling doaj.art-cf77ee522a274176b828dc3593f6241d2023-08-12T03:36:47ZengWileyKaohsiung Journal of Medical Sciences1607-551X2410-86502023-08-0139877978810.1002/kjm2.12696LDLR promotes autophagy‐mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathwayLei Liu0Yu‐Hui Sun1Ran An2Rong‐Jie Cheng3Nan Li4Jian‐Hua Zheng5Department of Obstetrics and Gynecology The Fourth Affiliated Hospital of Harbin Medical University Harbin Heilongjiang Province People's Republic of ChinaDepartment of Obstetrics and Gynecology The First Affiliated Hospital of Harbin Medical University Harbin Heilongjiang Province People's Republic of ChinaDepartment of Obstetrics and Gynecology The Fourth Affiliated Hospital of Harbin Medical University Harbin Heilongjiang Province People's Republic of ChinaDepartment of Obstetrics and Gynecology The Fourth Affiliated Hospital of Harbin Medical University Harbin Heilongjiang Province People's Republic of ChinaDepartment of Pathology The Fourth Affiliated Hospital of Harbin Medical University Harbin Heilongjiang Province People's Republic of ChinaDepartment of Obstetrics and Gynecology The First Affiliated Hospital of Harbin Medical University Harbin Heilongjiang Province People's Republic of ChinaAbstract Autophagy is one of the underlying causes of resistance to many antitumor drugs, including cisplatin (DDP). The low‐density lipoprotein receptor (LDLR) is a regulator of ovarian cancer (OC) progression. However, whether LDLR regulates DDP resistance in OC via autophagy‐related pathways remains unclear. LDLR expression was measured by quantitative real‐time PCR, western blot (WB) and IHC staining. A Cell Counting Kit 8 assay was employed to evaluate DDP resistance and cell viability, and flow cytometry was used to assess apoptosis. WB analysis was employed to evaluate the expression of autophagy‐related proteins and PI3K/AKT/mTOR signaling pathway proteins. The autophagolysosomes and the fluorescence intensity of LC3 were observed by transmission electron microscopy and immunofluorescence staining, respectively. A xenograft tumor model was established to explore the role of LDLR in vivo. LDLR was highly expressed in OC cells, which was correlated with disease progression. In DDP‐resistant OC cells, high LDLR expression was related to DDP resistance and autophagy. Downregulation of LDLR repressed autophagy and growth in DDP‐resistant OC cell lines by activating the PI3K/AKT/mTOR pathway, and these effects were eliminated by an mTOR inhibitor. In addition, LDLR knockdown also reduced OC tumor growth by suppressing autophagy associated with the PI3K/AKT/mTOR pathway. LDLR promoted autophagy‐mediated DDP resistance in OC associated with the PI3K/AKT/mTOR pathway, indicating that LDLR might be a new target to prevent DDP resistance in OC patients.https://doi.org/10.1002/kjm2.12696autophagycisplatin resistancelow‐density lipoprotein receptorovarian cancer
spellingShingle Lei Liu
Yu‐Hui Sun
Ran An
Rong‐Jie Cheng
Nan Li
Jian‐Hua Zheng
LDLR promotes autophagy‐mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway
Kaohsiung Journal of Medical Sciences
autophagy
cisplatin resistance
low‐density lipoprotein receptor
ovarian cancer
title LDLR promotes autophagy‐mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway
title_full LDLR promotes autophagy‐mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway
title_fullStr LDLR promotes autophagy‐mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway
title_full_unstemmed LDLR promotes autophagy‐mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway
title_short LDLR promotes autophagy‐mediated cisplatin resistance in ovarian cancer associated with the PI3K/AKT/mTOR signaling pathway
title_sort ldlr promotes autophagy mediated cisplatin resistance in ovarian cancer associated with the pi3k akt mtor signaling pathway
topic autophagy
cisplatin resistance
low‐density lipoprotein receptor
ovarian cancer
url https://doi.org/10.1002/kjm2.12696
work_keys_str_mv AT leiliu ldlrpromotesautophagymediatedcisplatinresistanceinovariancancerassociatedwiththepi3kaktmtorsignalingpathway
AT yuhuisun ldlrpromotesautophagymediatedcisplatinresistanceinovariancancerassociatedwiththepi3kaktmtorsignalingpathway
AT ranan ldlrpromotesautophagymediatedcisplatinresistanceinovariancancerassociatedwiththepi3kaktmtorsignalingpathway
AT rongjiecheng ldlrpromotesautophagymediatedcisplatinresistanceinovariancancerassociatedwiththepi3kaktmtorsignalingpathway
AT nanli ldlrpromotesautophagymediatedcisplatinresistanceinovariancancerassociatedwiththepi3kaktmtorsignalingpathway
AT jianhuazheng ldlrpromotesautophagymediatedcisplatinresistanceinovariancancerassociatedwiththepi3kaktmtorsignalingpathway